Literature DB >> 22125799

Foreword. A comprehensive review of bupropion.

Malcolm Lader1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22125799     DOI： 10.2165/11596410-000000000-00000

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  9 in total

1.  Bupropion-SR in treatment of social phobia.

Authors:  N P Emmanuel; O Brawman-Mintzer; W A Morton; S W Book; M R Johnson; J P Lorberbaum; J C Ballenger; R B Lydiard
Journal:  Depress Anxiety       Date:  2000       Impact factor: 6.505

Review 2.  ADHD through the life span: the role of bupropion in treatment.

Authors:  D P Cantwell
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

3.  Meta-analysis: pharmacologic treatment of obesity.

Authors:  Zhaoping Li; Margaret Maglione; Wenli Tu; Walter Mojica; David Arterburn; Lisa R Shugarman; Lara Hilton; Marika Suttorp; Vanessa Solomon; Paul G Shekelle; Sally C Morton
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

Review 4.  Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.

Authors:  Alessandro Serretti; Alberto Chiesa
Journal:  J Clin Psychopharmacol       Date:  2009-06       Impact factor: 3.153

Review 5.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Toshiaki A Furukawa; Georgia Salanti; John R Geddes; Julian Pt Higgins; Rachel Churchill; Norio Watanabe; Atsuo Nakagawa; Ichiro M Omori; Hugh McGuire; Michele Tansella; Corrado Barbui
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

6.  A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

Authors:  P Tønnesen; S Tonstad; A Hjalmarson; F Lebargy; P I Van Spiegel; A Hider; R Sweet; J Townsend
Journal:  J Intern Med       Date:  2003-08       Impact factor: 8.989

7.  A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.

Authors:  Stephen M. Stahl; James F. Pradko; Barbara R. Haight; Jack G. Modell; Carol B. Rockett; Susan Learned-Coughlin
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

8.  Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Vincenza Snow; Thomas D Denberg; Mary Ann Forciea; Douglas K Owens
Journal:  Ann Intern Med       Date:  2008-11-18       Impact factor: 25.391

9.  Pharmacologic modification of psychosexual dysfunction.

Authors:  T L Crenshaw; J P Goldberg; W C Stern
Journal:  J Sex Marital Ther       Date:  1987
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.